Richard N Kender is Director of Syneos Health, Inc.. Currently has a direct ownership of 7,148 shares of SYNH, which is worth approximately $0. The most recent transaction as insider was on May 23, 2017, when has been sold 2,693 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.15K
0% 3M change
0% 12M change
Total Value Held $0

Richard N Kender Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 23 2017
BUY
Grant, award, or other acquisition
-
2,693 Added 27.37%
7,148 Class A Common Stock
May 24 2016
BUY
Grant, award, or other acquisition
-
2,231 Added 33.37%
4,455 Class A Common Stock
Jun 05 2015
BUY
Grant, award, or other acquisition
-
1,550 Added 41.07%
2,224 Class A Common Stock
Dec 08 2014
BUY
Grant, award, or other acquisition
-
674 Added 50.0%
674 Class A Common Stock

Also insider at

BCYC
BICYCLE THERAPEUTICS plc Healthcare
MCRB
Seres Therapeutics, Inc. Healthcare
LGVN
Longeveron Inc. Healthcare
OMGA
Omega Therapeutics, Inc. Healthcare
RNK

Richard N Kender

Director
Raleigh, NC

Track Institutional and Insider Activities on SYNH

Follow Syneos Health, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SYNH shares.

Notify only if

Insider Trading

Get notified when an Syneos Health, Inc. insider buys or sells SYNH shares.

Notify only if

News

Receive news related to Syneos Health, Inc.

Track Activities on SYNH